tradingkey.logo

Movano Inc

MOVE
13.830USD
+9.060+189.94%
Horarios del mercado ETCotizaciones retrasadas 15 min
11.48MCap. mercado
PérdidaP/E TTM

Más Datos de Movano Inc Compañía

Movano Inc., doing business as Movano Health, is engaged in developing a suite of healthcare solutions to bring medical-grade data to the forefront of wearables. Its devices deliver data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and translating it into personalized and intelligent insights. Its product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.

Información de Movano Inc

Símbolo de cotizaciónMOVE
Nombre de la empresaMovano Inc
Fecha de salida a bolsaMar 23, 2021
Director ejecutivoDr. John Mastrototaro, Ph.D.
Número de empleados32
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 23
Dirección6800 Koll Center Parkway
CiudadPLEASANTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal94566
Teléfono14083931209
Sitio Webhttps://movanohealth.com/
Símbolo de cotizaciónMOVE
Fecha de salida a bolsaMar 23, 2021
Director ejecutivoDr. John Mastrototaro, Ph.D.

Ejecutivos de Movano Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John Mastrototaro, Ph.D.
Dr. John Mastrototaro, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.17K
+67.21%
Mr. Michael Aaron Leabman
Mr. Michael Aaron Leabman
Founder, Chief Technology Officer, Director
Founder, Chief Technology Officer, Director
21.62K
--
Mr. Brian Cullinan
Mr. Brian Cullinan
Independent Director
Independent Director
15.15K
+27.97%
Mr. Ruben Caballero
Mr. Ruben Caballero
Independent Director
Independent Director
8.83K
+30.59%
Dr. Shaheen Wirk, M.D.
Dr. Shaheen Wirk, M.D.
Independent Director
Independent Director
6.84K
+43.33%
Mr. Jeremy (J.) Cogan
Mr. Jeremy (J.) Cogan
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jill Schmidt
Ms. Jill Schmidt
IR Contact Officer
IR Contact Officer
--
--
Ms. Emily Wang Fairbairn
Ms. Emily Wang Fairbairn
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John Mastrototaro, Ph.D.
Dr. John Mastrototaro, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.17K
+67.21%
Mr. Michael Aaron Leabman
Mr. Michael Aaron Leabman
Founder, Chief Technology Officer, Director
Founder, Chief Technology Officer, Director
21.62K
--
Mr. Brian Cullinan
Mr. Brian Cullinan
Independent Director
Independent Director
15.15K
+27.97%
Mr. Ruben Caballero
Mr. Ruben Caballero
Independent Director
Independent Director
8.83K
+30.59%
Dr. Shaheen Wirk, M.D.
Dr. Shaheen Wirk, M.D.
Independent Director
Independent Director
6.84K
+43.33%
Mr. Jeremy (J.) Cogan
Mr. Jeremy (J.) Cogan
Chief Financial Officer
Chief Financial Officer
--
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: mar., 19 de ago
Actualizado: mar., 19 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Appel (Peter A)
7.77%
Mastrototaro (John)
4.93%
Clayton Partners LLC
4.79%
Mairs and Power, Inc.
4.50%
Cogan (Jeremy D.)
4.44%
Otro
73.57%
Accionistas
Accionistas
Proporción
Appel (Peter A)
7.77%
Mastrototaro (John)
4.93%
Clayton Partners LLC
4.79%
Mairs and Power, Inc.
4.50%
Cogan (Jeremy D.)
4.44%
Otro
73.57%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
29.65%
Investment Advisor
6.13%
Hedge Fund
5.05%
Investment Advisor/Hedge Fund
3.30%
Venture Capital
0.30%
Research Firm
0.23%
Otro
55.33%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
49
125.47K
15.03%
+1.75K
2025Q2
56
3.25M
46.13%
+457.93K
2025Q1
56
2.83M
40.61%
+410.10K
2024Q4
56
2.31M
34.88%
+869.72K
2024Q3
55
2.03M
30.72%
+612.32K
2024Q2
55
2.06M
31.25%
+706.69K
2024Q1
50
720.48K
20.03%
+1.88K
2023Q4
47
725.57K
20.17%
+32.23K
2023Q3
46
940.36K
29.66%
+64.17K
2023Q2
45
886.33K
28.12%
+52.17K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Appel (Peter A)
648.80K
7.77%
--
--
Aug 26, 2025
Mastrototaro (John)
246.22K
2.97%
--
--
Aug 26, 2025
Clayton Partners LLC
400.00K
4.79%
+256.52K
+178.79%
Jun 30, 2025
Mairs and Power, Inc.
375.34K
4.5%
--
--
Jun 30, 2025
Cogan (Jeremy D.)
236.30K
2.85%
--
--
Aug 26, 2025
Fairbairn (Malcolm P.)
367.57K
4.4%
--
--
Aug 26, 2025
Robert W. Baird & Co. Inc.
218.73K
2.62%
-105.21K
-32.48%
Jun 30, 2025
Leabman (Michael Aaron)
216.16K
2.59%
--
--
Aug 26, 2025
Cullinan (Brian)
118.36K
1.43%
--
--
Aug 26, 2025
Fairbairn Emily Wang
120.29K
1.44%
-367.57K
-75.34%
Aug 26, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Fecha
Tipo
Relación
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
KeyAI